Tuesday, December 07, 2021 8:08:26 AM
7:58 am ET December 7, 2021 (Benzinga) Print
Recursion (NASDAQ:RXRX), a clinical-stage biotechnology company decoding biology to radically improve lives by industrializing drug discovery, development and beyond through disruptive innovation, today announced a transformational collaboration with Roche ((SIX: RO, ROG, OTCQX:RHHBY) and Genentech, a member of the Roche Group. Recursion will work with both Roche and Genentech's R&D units to leverage technology-enabled drug discovery through the Recursion Operating System (OS) to more rapidly identify novel targets and advance medicines in key areas of neuroscience as well as in an oncology indication. Under the terms of the agreement, Recursion will receive an upfront payment of $150 million and is eligible for additional performance-based research milestones. Under the collaboration, Roche and Genentech (combined) may initiate up to 40 programs, each of which, if successfully developed and commercialized, could yield more than $300M in development, commercialization and net sales milestones for Recursion, as well as tiered royalties on net sales.
New York Yankees and Duke Basketball
Recent RXRX News
- Recursion Announces Completion of NVIDIA-Powered BioHive-2, the Largest Supercomputer in Pharmaceutical Industry • GlobeNewswire Inc. • 05/13/2024 09:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:11:55 PM
- Recursion Provides Business Updates and Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/09/2024 08:01:00 PM
- Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9 • GlobeNewswire Inc. • 05/02/2024 12:00:00 PM
- Recursion to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 05/01/2024 12:01:00 PM
- Altitude Lab Secures Small Business Administration Growth Fund Accelerator Grant to Launch Horizon, a Commercialization Partnering Program • GlobeNewswire Inc. • 04/30/2024 12:00:00 PM
- Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer • GlobeNewswire Inc. • 04/16/2024 12:00:00 PM
- Recursion to Participate in Upcoming Investor Conference • GlobeNewswire Inc. • 04/02/2024 12:00:00 PM
- Recursion Publishes Annual Environmental, Social and Governance Report • GlobeNewswire Inc. • 03/26/2024 12:00:00 PM
- Recursion Announces Plans to Open New Office in London • GlobeNewswire Inc. • 03/11/2024 08:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 12:08:51 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 11:53:38 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2024 10:39:44 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2024 09:59:44 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 09:18:46 PM
- Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community • GlobeNewswire Inc. • 03/01/2024 07:58:00 PM
- Recursion to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 03/01/2024 12:59:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 01:25:26 PM
- Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results • GlobeNewswire Inc. • 02/27/2024 09:05:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2024 12:22:51 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/22/2024 11:13:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 10:37:37 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2024 09:29:43 PM
- Recursion to Host Public L(earnings) Call on February 27 • GlobeNewswire Inc. • 02/20/2024 12:59:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2024 12:59:37 AM
FEATURED POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • May 14, 2024 10:09 AM
FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM
VAYK Added New Manager for Expansion into $64 Billion Domestic Short-term Rental Market • VAYK • May 14, 2024 9:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM